IE1 is the principal early transregulator of Autographa californica multicapsid nuclear polyhedrosis virus (AcMNPV). The 582-residue protein stimulates viral transcription and binds as a dimer to 28-bp palindromic repeats (28-mers) comprising the AcMNPV homologous region (hr) transcription enhancers. To define IE1 domains responsible for hr-dependent transactivation, we first constructed a series of IE1 fusions to the DNA binding domain of the yeast GAL4 transactivator. In transfection assays, GAL4-IE1 fusions stimulated transcription from a TATA-containing AcMNPV promoter only upon cis linkage to GAL4 DNA binding sites. IE1 N-terminal residues 8 to 118 were sufficient for GAL4-binding-site-dependent transactivation. To identify IE1 residues required for hr interaction, we tested a series of IE1 mutations for 28-mer binding by using electrophoretic mobility shift assays. Deletion of IE1 residues other than the N-terminal transactivation domain eliminated 28-mer binding. Current evidence indicates that immediate-early gene 1 (ie-1) is the principal transregulator of early gene expression by the baculovirus Autographa californica multicapsid nuclear polyhedrosis virus (AcMNPV). The 67-kDa ie-1 gene product (IE1) is a potent transactivator of early viral genes in plasmid transfection assays (3, 16, 18, 24, 31, 35, 44) . Moreover, ie-1 is required in plasmid replication assays and thus may contribute directly or indirectly to viral DNA replication (21, 32). Lastly, as indicated by replication defects exhibited by the AcMNPV mutant tsB821, carrying a temperature-sensitive lesion in ie-1, IE1 is required for proper timing of AcMNPV replication (7, 43) . Despite these apparent contributions of IE1 to productive baculovirus infection, the molecular mechanisms of IE1 function are poorly understood.
IE1 is the principal early transregulator of Autographa californica multicapsid nuclear polyhedrosis virus (AcMNPV). The 582-residue protein stimulates viral transcription and binds as a dimer to 28-bp palindromic repeats (28-mers) comprising the AcMNPV homologous region (hr) transcription enhancers. To define IE1 domains responsible for hr-dependent transactivation, we first constructed a series of IE1 fusions to the DNA binding domain of the yeast GAL4 transactivator. In transfection assays, GAL4-IE1 fusions stimulated transcription from a TATA-containing AcMNPV promoter only upon cis linkage to GAL4 DNA binding sites. IE1 N-terminal residues 8 to 118 were sufficient for GAL4-binding-site-dependent transactivation. To identify IE1 residues required for hr interaction, we tested a series of IE1 mutations for 28-mer binding by using electrophoretic mobility shift assays. Deletion of IE1 residues other than the N-terminal transactivation domain eliminated 28-mer binding. Of Current evidence indicates that immediate-early gene 1 (ie-1) is the principal transregulator of early gene expression by the baculovirus Autographa californica multicapsid nuclear polyhedrosis virus (AcMNPV). The 67-kDa ie-1 gene product (IE1) is a potent transactivator of early viral genes in plasmid transfection assays (3, 16, 18, 24, 31, 35, 44) . Moreover, ie-1 is required in plasmid replication assays and thus may contribute directly or indirectly to viral DNA replication (21, 32) . Lastly, as indicated by replication defects exhibited by the AcMNPV mutant tsB821, carrying a temperature-sensitive lesion in ie-1, IE1 is required for proper timing of AcMNPV replication (7, 43) . Despite these apparent contributions of IE1 to productive baculovirus infection, the molecular mechanisms of IE1 function are poorly understood.
As assayed by plasmid transfections, IE1-mediated transcriptional activation is significantly amplified when the affected promoter is cis linked to homologous region (hr) enhancer sequences from AcMNPV (3, 15, 17, 31, 35, 39, 44) . Ranging in size from 30 to 800 bp, eight hr enhancer elements are dispersed throughout the circular AcMNPV genome (134 kbp) (1, 8) and may function as origins of viral DNA replication (22, 28, 36) . The 28-bp palindromic repeats (28-mer) comprising the hrs are the minimal sequence required for orientation-and position-independent enhancer activity (44, 45) and hr-mediated plasmid DNA replication (28, 36) . IE1 interaction with the hrs is mediated in part by the palindromic 28-mers (6, 13, 14, 26, 45) . In particular, nucleotide substitutions within the 28-mer that eliminate IE1 binding also abolish 28-mer-mediated transactivation (45) and transient DNA replication (26) . Thus, IE1 stimulation of hr-mediated enhancement or DNA replication may require IE1 binding to hr sequences.
IE1 binds to the palindromic 28-mer as a dimer, and optimal IE1 interaction requires both 28-mer half-sites (45) . Although a single half-site is sufficient for IE1 interaction, both half-sites with a precise spacing are required for enhancer activity and DNA replication (14, 26, 44, 45) . Thus, a critical step in IE1 function is the proper interaction of oligomeric IE1 with the 28-mer. However, the molecular events by which IE1 subsequently stimulates hr-dependent transcription or DNA replication are unknown. Essential to defining these IE1-mediated events is the identification and characterization of the protein domains involved.
To first test the hypothesis that IE1 binding to DNA contributes to hr enhancer activity, we constructed a series of fusions between IE1 and the DNA binding domain (DBD) of the yeast GAL4 transcriptional activator. This strategy enabled us to investigate IE1 transactivation in response to DNA binding mediated independently by the GAL4 DBD and thereby map IE1 residues sufficient for transactivation. We report here that GAL4-IE1 fusions stimulated TATA-dependent transcription but only when the promoter was cis-linked to GAL4 DNA binding sites. N-terminal IE1 residues 8 to 118 were sufficient for maximal GAL4-IE1 transactivation. These findings confirmed and extend a deletion analysis by Kovacs et al. (23) , which showed that the N and C termini of IE1 are required for transactivation and hr complex formation, respectively. Thus, to further distinguish IE1 residues required for transactivation and oligomerization-dependent DNA binding, we tested the capacity of an extensive series of IE1 mutations to bind to an hr5 28-mer-containing DNA probe in electrophoretic mobility shift assays (EMSAs). To avoid potential problems of intracellular instability, we synthesized mutated forms of IE1 in vitro and thereby identified several regions required for 28-mer interaction. In particular, mutations within a 4-3 repeat of hydrophobic residues (34) near the IE1 C terminus eliminated DNA binding as well as the capacity to compete with wild-type IE1 for the 28-mer. Collectively, these data indicate a critical role for IE1 oligomerization in hr enhancer activity. Moreover, they are consistent with a model in which localization of the N-terminal IE1 transactivation domains to the basal transcription complex by DNA binding contributes to stimulation of early viral transcription.
MATERIALS AND METHODS

Cells and transfections.
Spodoptera frugiperda IPLB-SF21 (SF21) (54) cells were propagated in TC100 growth medium (GIBCO Laboratories) supplemented with 2.6 mg of tryptose broth per ml and 10% heat-inactivated fetal bovine serum. Calcium phosphate transfections of plasmid DNA were performed as described previously (39, 45) .
Plasmid construction. (i) GAL4-IE1 expression plasmids. pIE1prm/GAL4-DBD was constructed by inserting the 542-bp HindIII-BamHI fragment (end repaired) that contains the GAL4 DBD (amino acid residues 1 to 147) and the influenza virus hemagglutinin epitope of plasmid pAS2 (57) into end-repaired BglII and BstBI sites downstream of the ie-1 promoter (nucleotides Ϫ546 to ϩ32 relative to the RNA start site, ϩ1) of plasmid pIE1 Bg2 (39) . Insertion of the ie-1-containing 2,038-bp MluI-BamHI fragment (end repaired) from pSP64/IE1 (45) into the SmaI site of pAS2 generated pAS2/IE1(8-582). Construction of pIE1prm/GAL4-IE1(8-582) was identical to that of pIE1prm/GAL4-DBD except that the inserted 2,584-bp HindIII-BamHI fragment was derived from pAS2/ IE1(8-582). pIE1prm/GAL4-DBD(⌬MCS) was derived by SalI and XbaI digestion of pIE1prm/GAL4-DBD, end repair with Klenow fragment, and religation. pIE1prm/GAL4-DBDx was generated by BamHI digestion, end repair with Klenow fragment, and ligation to an XbaI amber stop codon linker (5Ј-CTAGTCT AGACTAG-3Ј). pIE1prm/GAL4-IE1(8-51), pIE1prm/GAL4-IE1(8-217), and pIE1prm/GAL4-IE1(53-217) were constructed by insertion of end-repaired MluI-EcoRV, MluI-NdeI, and EcoRV-NdeI fragments, respectively, from pSP64/ IE1 into the SmaI site of pIE1prm/GAL4-DBDx. pIE1prm/GAL4-IE1(120-217) was constructed by insertion of an end-repaired NdeI-BsmI fragment from pSP64/IE1 into the NcoI site of pIE1prm/GAL4-DBDx. NdeI digestion of pIE1prm/GAL4-IE1(8-582) and intramolecular ligation generated pIE1prm/ GAL4-IE1(217-582). The chloramphenicol acetyltransferase (CAT) reporter plasmid pG 5 35K BAS -CAT/PA was generated by inserting the end-repaired HindIII-XbaI fragment, containing five GAL4 binding sites, from plasmid (GAL4) 5 /E1bTATA (29) into the end-repaired BglII site of pBAS35K-CAT/PA (44) .
(ii) ie-1 deletions. pSP64/IE1 (45) (iv) ie-1 substitutions. pIE1/BS was modified by site-directed mutagenesis (25) using oligonucleotides 5Ј-CCGATTACAAACATATGATGCGCAAATGCAT TATATTTTTG-3Ј, 5Ј-GCAATGTAGTGCTCTCTGCTGCGTTAACTTTAC CGATTAC-3Ј, 5Ј-TAAAGCTAACAATTTGAGCTCATTATTGTGGTCTGT AGTGCTCTC-3Ј, 5Ј-CGGAACCAGACCCTGGAGCTCTAAAGCTAAGTC TTTTAACAAATTATTG-3Ј, 5Ј-CCGCAAACGTTATTTCGTCGGAGTCCG GTACCAGACCCTGTAATAT-3Ј, and 5Ј-TTTATATTTACAATTAAGCTTT TGTTCCTCAAACGTGTCAGCGTCGGACAA-3Ј (nucleotide substitutions are underlined). The 344-bp SphI-BstBI fragment of the resulting plasmids was inserted into the corresponding sites of pSP64/IE1 to generate pSP64/IE1(524/ 526), pSP64/IE1(537/538), pSP64/IE1(543/547), pSP64/IE1(550/554), pSP64/IE1 (561/564), and pSP64/IE1(565/568), respectively. All mutations were verified by nucleotide sequencing.
CAT assays. Freeze-thaw extracts from plasmid-transfected SF21 cells were assayed for CAT as described previously (10) . Acetylation of [
14 C]chloramphenicol was quantified by using a PhosphorImager (Molecular Dynamics).
In vitro protein synthesis. Rabbit reticulocyte lysates were used in coupled in vitro transcription-translation reactions according to the manufacturer's protocol (TNT system; Promega). Circular plasmid templates (200 ng) were added singly or together to a reaction mixture (10 l) containing reticulocyte lysate, amino acids, SP6 polymerase, and RNasin (Promega). After a 1.5-h incubation at 30°C, reactions were adjusted to a final concentration of 15% glycerol and stored at Ϫ80°C. To radiolabel in vitro-synthesized proteins, reactions were supplemented with Tran 35 S-label (ICN). 28-mer-containing hr5 DNA probe. The primers 5Ј-CACACAGGAAACAG CTATGAC-3Ј and 5Ј-CGGCCAGTGAATTGTAATACG-3Ј were used to PCR amplify sequences of plasmid phr5DA(Ϫ) (45) . The 28-mer-containing PCR fragment was purified by using Wizard PCR Preps (Promega) and digested with XbaI and XhoI. The resulting 131-bp fragment was dephosphorylated, purified by agarose gel electrophoresis, and end labeled with T4 kinase and [␣-
32 P]ATP. EMSAs. Protein-DNA complexes using in vitro-synthesized IE1 and the 28-mer DNA probe were subjected to nondenaturing 5% polyacrylamide-Trisglycine gel electrophoresis for 3 to 5 h as described previously (45) .
Image processing. Autoradiograms were scanned at a resolution of 300 dots/ in. by using a Microtek Scanmaker III equipped with a transparency adapter. The resulting files were printed from Adobe Photoshop 3.0 by using a Tektronix Phaser 440 dye sublimation printer.
RESULTS
IE1 transactivation through direct DNA binding.
Mutations within the hr5 28-mer that disrupt IE1 binding and eliminate 28-mer-mediated transcriptional activation support a model wherein IE1 transactivation involves sequence-specific DNA binding (23, 45) . To test IE1's capacity to transactivate by direct DNA binding, we constructed GAL4-IE1 hybrids in which the GAL4 DBD (residues 1 to 147) was fused to IE1 (Fig. 1A) . Placed under control of the ie-1 promoter, the gal4-ie-1 gene fusions were tested for the capacity to transactivate a viral promoter that contained tandem upstream GAL4 DNA binding sites, allowing direct interaction between IE1 and the promoter. GAL4-IE1 transactivation was monitored in transient expression assays in which SF21 cells were transfected with a reporter plasmid that contained the CAT gene under control of the basal promoter of the AcMNPV p35 gene with (G 5 35K BAS -CAT) or without (35K BAS -CAT) GAL4 DNA binding sites (Fig. 1B) . The minimal p35 basal promoter contains a TATA element and early RNA start site (ϩ1) but lacks its viral upstream activating region (10, 39, 44) .
GAL4-IE1(8-582), containing all but the first seven residues of IE1, transactivated the p35 basal promoter in a GAL4-binding-site-dependent manner (Fig. 1C) . This full-length IE1 fusion exhibited low-level reporter transactivation in the ab-sence of GAL4 binding sites (35K BAS -CAT) but stimulated reporter expression 27-fold when GAL4 binding sites were present (G 5 35K BAS -CAT). In contrast, the presence of GAL4 DNA binding sites had no effect on the capacity of wild-type IE1 to transactivate the p35 basal promoter, since levels of G 5 35K BAS -CAT and 35K BAS -CAT expression were similar (Fig. 1C) . The reduced transactivation of the p35 basal promoter lacking GAL4 sites by GAL4-IE1(8-582) compared to wild-type IE1 was likely due to differences in folding or stability of the larger fusion protein. The GAL4 DBD alone failed to stimulate either reporter, which was inactive in the absence of IE1. Collectively, these data demonstrated that GAL4-IE1 transactivation depended on GAL4-binding-site interaction and suggested that IE1 can transactivate by DNA binding in a sequence-specific manner.
Identification of IE1 domains sufficient for GAL4-IE1 transactivation. To map IE1 residues responsible for GAL4-targeted transactivation, various segments of IE1 were fused to the GAL4 DBD ( Fig. 2A) and tested for transactivation of the GAL4-binding site-containing CAT reporter G 5 35K BAS -CAT (Fig. 2B) . All GAL4-IE1 fusions that included residues between 8 and 118 stimulated reporter expression. In particular, GAL4-IE1(8-118) increased expression 500-fold over that of the GAL4 DBD alone, a level five times higher than that of full-length GAL4-IE1(8-582). Nonoverlapping fusions GAL4-IE1(8-51) and GAL4-IE1(53-217) also exhibited stimulatory activity, suggesting that the transactivation domain of IE1 is either multipartite or tolerant to partial deletion. In contrast, GAL4-IE1 fusions that contained IE1 residues 120 to 217, 217 to 414, and 217 to 582 exhibited no stimulatory activity. The possibility that these fusions containing residues 120 to 582 were unstable in transfected cells was not ruled out. However, the presence of these residues did not destabilize the fulllength GAL4-IE1(8-582) fusion. Taken together, these data indicated that N-terminal IE1 residues are sufficient for GAL4-targeted transactivation. Since IE1 residues 1 to 8 are dispensable for transactivation (23) , our data suggest that the IE1 transactivation domain(s) lies between residues 8 and 118.
DNA binding and oligomerization by IE1 deletions. Previous findings that dimeric IE1 interacts with the palindromic 28-mer suggested that both DNA binding and oligomerization contribute to hr-dependent transactivation by IE1. Thus, to further map IE1 domains involved in 28-mer binding and oligomerization, we first constructed a series of internal ie-1 deletions (Fig. 3) . The mutated forms of IE1 were synthesized by using coupled transcription-translation reactions and subsequently tested for binding to a 28-mer-containing hr5 DNA probe (Fig.  3) in EMSAs. This in vitro approach provided a means to stably synthesize IE1 mutations at comparable levels and circumvented potential in vivo instability (see below; also data not shown).
In EMSAs, IE1 deletion IE1 ⌬9-52 bound as a homodimer to the 28-mer probe with an affinity similar to that of wild-type IE1 (Fig. 4A, lanes 2 and 3) , as expected (45) . The increased mobility of the complexes containing deleted IE1 is attributed to IE1's reduced size. In contrast to IE1
⌬9-52
, all other IE1 deletions exhibited reduced or no 28-mer binding. Of these, IE1
⌬53-143 exhibited the highest level of homodimeric binding to the probe (lane 6). In addition, low-level binding of IE1 ⌬144-155 was detected upon longer exposures (data not shown). Thus, the N-terminal 155 residues of IE1 are dispensable for minimal 28-mer interaction. Moreover, multiple regions within IE1 contribute directly or indirectly to complex formation.
To determine which IE1 deletions retained the capacity to oligomerize, in vitro-synthesized proteins were tested for heterodimerization with wild-type IE1 in 28-mer binding assays (Fig. 4B) ⌬144-155 and IE1 were detected (data not shown). Although IE1 ⌬13-156 failed to homodimerize, this deletion bound to the 28-mer as a heterodimer with wild-type IE1 (lane 4). However, all IE1 deletions that lacked residues C terminal to residue 156 failed to heterodimerize. Thus, N-terminal IE1 residues 9 to 155 are not required for IE1 oligomerization or DNA binding, but residues beyond 156 contribute directly or indirectly to both functions. The finding that deletion IE1
⌬13-156 bound DNA as a heterodimer but not as a homodimer also suggested that IE1 contains genetically separable DNA binding and oligomerization domains.
DNA binding and dimerization of insertion-mutated IE1.
To disrupt local secondary structure and thereby more precisely map domains required for protein-protein or protein-DNA interactions, we next constructed a series of ie-1 insertion mutations. BglII oligonucleotide linkers (8 to 12 bp) were placed throughout ie-1 to generate IE1 mutations containing three to five amino acid insertions at unique locations (Fig. 5A) . As determined by polyacrylamide gel electrophoresis of 35 S-labeled protein (Fig. 5B) , the levels of in vitro-synthesized IE1 were similar for all insertions . Insertions IE1  I70 , IE1  I118 ,  IE1  I143 , IE1  I414 , IE1  I418 , IE1  I513 , and IE1 I579 independently bound to the 28-mer DNA probe with various affinities in EMSAs (Fig. 5C) To determine which IE1 insertions retained the capacity to bind the 28-mer by heterodimerizing with a functional IE1, each was synthesized with the smaller functional IE1
⌬9-52 and subjected to EMSA (Fig. 5D ). All IE1 insertions that independently bound DNA also formed heterodimers with IE1 ⌬9-52 . The level of heterodimerization (Fig. 5D ) paralleled that of homodimerization (Fig. 5C) (Fig. 4) , the ability (ϩ) or inability (Ϫ) of each IE1 deletion to interact with the 28-mer DNA probe as a homodimer (homo-) or heterodimer (hetero-) with wild-type IE1 is indicated at the right. (Fig. 6, lanes 5 to 7) , IE1 ⌬9-52 homodimers were also depleted but without detection of DNA binding by heterodimers. This pattern suggested that IE1
I425 associated with IE1
⌬9-52 but the resulting heterodimers were defective for 28-mer binding. In contrast, IE1
⌬9-52 homodimers were detected even in the presence of a 25-fold excess of IE1 I553 (Fig.  6, lanes 8 to 10) . Thus, IE1
I553 failed to compete for IE1 ⌬9-52 subunits as efficiently as wild-type IE1 or IE1 I425 . These data suggested that the insertion at residue 425 disrupted DNA binding but not oligomerization, whereas the insertion at residue 553 abrogated IE1 oligomerization.
Requirement of a C-terminal hydrophobic 4-3 repeat for DNA binding. The failure of IE1 I553 to either bind DNA or block binding by wild-type IE1 suggested that the region encompassing residue 553 is critical for dimerization. Inspection of potential secondary structure within this region reveals a positively charged domain (residues 521 to 544, pI of 11.74) that precedes two putative amphipathic ␣-helices (residues 543 to 572) consisting of 4-3 repeats of hydrophobic residues (Fig.  7A ). This stretch within IE1 of AcMNPV and Orgyia pseudotsugata multicapsid nuclear polyhedrosis virus (OpMNPV) matches a consensus basic-helix-loop-helix (b-HLH) motif required for oligomerization of other transcriptional activators (Fig. 7B) . Insertion I553 interrupted the first helix, whereas deletion of the second helix caused loss of hr5 binding by IE1 (23) . Thus, to better define the role of the b-HLH-like domain, we substituted hydrophobic residues within the 4-3 repeat with acidic residues (Asp or Glu) and replaced basic residues within the positively charged region with Ala (Fig. 7A) . After verifying that the levels of in vitro-synthesized IE1 were similar for all substitutions (data not shown), each was assayed for 28-mer binding.
Substitution of hydrophobic residue pairs 543/547, 550/554, 561/564, and 565/568 within the IE1 4-3 repeats abolished 28-mer binding by each protein (IE1  L543D/L547E , IE1  L550D/I554E ,  IE1 L561D/A564E , and IE1 I565D/A568E ) (Fig. 8A, lanes 3 to 6) . Likewise, the 4-3 substitutions greatly reduced or eliminated 
FIG. 6. Interference of IE1
⌬9-52 binding to the 28-mer. IE1 ⌬9-52 was cosynthesized with increasing levels of wild-type (wt) IE1, IE1 I425 , or IE1 I553 , using molar ratios of 1:1 (lanes 2, 5, and 8), 1:10 (lanes 3, 6, and 9), and 1:25 (lanes 4, 7, and 10), and subjected to EMSA as described in the legend to , either alone (Fig. 8A, lane 2) or with IE1 ⌬9-52 (Fig. 8B, lane 5) . In contrast, neither Arg 524 or Lys 526 was required for DNA binding, since IE1
R524A/K526A bound DNA (Fig. 8A, lane 1) with an affinity comparable to that of wild-type IE1 (lane 7) and heterodimerized with IE1 ⌬9-52 (Fig. 8B, lane 4) . Thus, whereas Arg 537 and Arg 538 immediately adjacent to the 4-3 helices are required for DNA binding, basic residues N terminal to these helices are not.
DISCUSSION
IE1 transactivation through DNA binding. The current model that IE1-mediated transactivation of the AcMNPV hr enhancers requires DNA binding by IE1 is based on the finding that disruption of the minimal enhancer unit (28-mer) reduces IE1 binding and eliminates transcriptional enhancement (26, 45) . However, it remained to be established that IE1 binding at or near a basal promoter induces transcriptional stimulation. By using constructed GAL4-IE1 fusions, we have shown here that IE1 interaction with a minimal TATA-containing promoter through binding to GAL4 DNA sites stimulated transcription. GAL4-IE1 transactivation was GAL4-binding-site dependent and conferred a 14-to 140-fold increase in expression, depending on the IE1 residues included ( Fig. 1 and 2) . Interaction of GAL4-IE1 fusions with the GAL4-binding-sitecontaining DNA was confirmed by EMSA (40) . Thus, directed IE1 binding to a viral promoter was sufficient to activate transcription and further implies the involvement of DNA binding in IE1-mediated transactivation of 28-mer-linked viral promoters.
A common mechanism among transcriptional activators involves sequence-specific DNA binding that brings the activator into proximity with the promoter for assembly or stabilization of the transcription machinery (reviewed in references 2, 38, 46, 55, and 58). Transcriptional stimulation by virus-encoded activators is mediated by interaction with general host factors, including TATA binding protein and TFIIB (4, 12, 30, 33, 41, 49, 51) . By analogy, it is likely that upon recruitment to a promoter, IE1 interacts with components of the basal transcription complex. Nonetheless, hr binding alone is not sufficient for IE1-mediated transactivation since 28-mer half-sites interact with IE1 but lack enhancer activity (14, 44, 45) . Rather, IE1 binding to half-sites can inhibit transcription from AcMNPV promoters (27) . Thus, molecular events other than DNA binding are required for IE1 transactivation and remain to be defined. IE1 domain(s) sufficient for transactivation. GAL4 DBD fusions with various transcriptional activators have been used to identify residues involved in transactivation (11, 19, 29, 37, 48, 50) . By testing GAL4 fusions containing different segments of IE1 (Fig. 2) , we have mapped the IE1 transactivation domain(s) to residues 8 through 118 (Fig. 9) . Resembling the acidic transactivation domains of other transcriptional activators (reviewed in reference 53), the N-terminal stretch of IE1 from residues 8 to 118 is highly acidic, containing 18% Asp and Glu residues (Ϫ15 net charge) (18) . GAL4-IE1 fusions containing nonoverlapping residues 8 to 51 and 53 to 217 also exhibited GAL4-dependent transactivation, although at levels lower than that conferred by residues 8 to 118. Thus, the entire acidic stretch was not required for transcriptional stimulation and suggested the presence of multiple transactivating domains. A similar division of acidic residues exists within the activation domain of herpes simplex virus virion protein VP16, in which aromatic and hydrophobic residues are also critical (42, 48) . IE1 residues 120 to 582 were not required for GAL4 transactivation, nor did these residues exhibit independent transactivation of the basal promoter (Fig. 2) . Thus, our data suggest that IE1 residues sufficient for transactivation are confined to the N terminus (Fig. 9 ). These findings are consistent with a previous study that used progressive truncations to show that the IE1 N terminus is required for transactivation of hr-linked viral promoters (23) . IE1 residues required for 28-mer interaction. Consistent with the dispensability of the IE1 N terminus for DNA binding (23) , mutated forms of IE1 with deletions or insertions between residues 9 to 155 retained the capacity to bind a 28-mercontaining DNA probe in EMSAs (Fig. 4 and 5) . Whereas removal of IE1 residues 9 to 52 had little effect, removal of residues 53 to 143 or 144 to 155 reduced 28-mer binding (Fig.  4A) . Residues 53 to 155 may therefore contribute to DNA binding but are not essential. In contrast, all internal deletions that removed IE1 sequences C-terminal to residue 155 eliminated 28-mer binding ( Fig. 3 and 4) . Thus, multiple IE1 domains are involved in DNA binding or participate indirectly by contributing to protein structure. This conclusion was supported by the finding that multiple insertion mutations outside the N-terminal transactivation domain impaired homodimeric binding of the 28-mer ( Fig. 5A and C) .
Among the IE1 insertions that failed to bind DNA as homodimers, two distinct classes were identified. The first class (including IE1  I156 , IE1  I243 , IE1  I391 , and IE1  I462 ) bound DNA but only as heterodimers with IE1
⌬9-52
. On the basis of their capacity to bind DNA by association with functional IE1, these insertions contained a functional oligomerization domain. Thus, each mutation either disrupted a DBD or altered IE1 structure that abolished DNA binding but not oligomerization. It is noteworthy that each of the regions flanking insertions at residues 156, 243, 391, and 462 is conserved among nuclear polyhedrosis virus ie-1 genes. Of particular interest is the region flanking residue 156, which because of its high content of basic residues (6 of 10 and 9 of 17 Lys/Arg residues for AcMNPV and OpMNPV IE1s, respectively) may be directly involved in contacting DNA. Consistent with a direct role in DNA binding, partial deletion of these basic residues (IE1 ⌬13-156 and IE1 ⌬144-155 ) or insertional disruption (IE1 I156 ) caused loss of homodimeric DNA binding but not oligomerization (Fig. 4 and 5) .
The second class of IE1 insertion mutations (IE1  I425 and  IE1 I553 ) caused loss of homo-and heterodimeric binding to DNA (Fig. 5) . In a manner analogous to wild-type IE1, excess IE1 I425 interfered with 28-mer binding by functional IE1
, suggesting an interaction between both proteins (Fig. 6) . However, the absence of detectable mixed-subunit complexes (IE1 I425 -IE1 ⌬9-52 ) indicated that this protein interaction impeded DNA binding by heterodimeric IE1 ⌬9-52 . Consistent with a critical role in IE1 function, the region flanked by residue 425 is highly conserved (15 of 16 residues are identical between AcMNPV and OpMNPV IE1) (52) and is the location of the substitution A 432 V (Fig. 9 ) that confers temperature sensitivity to hr binding by IE1 of AcMNPV mutant tsB821 (7, 43) . In contrast to IE1 I425 , insertion IE1 I553 failed to associate with functional IE1 and block 28-mer binding (Fig. 6 ). This property suggested that IE1 I553 's loss of DNA binding activity was due to disruption of oligomerization.
IE1 oligomerization. The observed restoration of DNA binding activity of IE1 insertions defective for homodimeric binding to the 28- mer (IE1  I156 , IE1   I243 , IE1 I391 , and IE1 I462 ) by association with functional IE1 argues that oligomerization is critical to DNA binding. Supporting this conclusion was the finding that insertion I553 as well as substitutions of hydrophobic residues within the 4-3 repeat extending from IE1 residues 543 to 568 severely impaired homo-and heterodimeric binding of IE1 to DNA (Fig. 8) . By analogy to the b-HLH motifs of other transcriptional activators (34) , the hydrophobic face of the predicted IE1 ␣-helices (Fig. 7) is expected to be involved in protein-protein interaction. Thus, the loss of homo-and heterodimeric DNA binding by mutations that disrupted the putative IE1 helices is attributed to elimination of oligomerization. It remains to be shown whether the C-terminal b-HLH-like motif is required for IE1 dimerization in the absence of DNA binding. Kovacs et al. showed that deletion of IE1 residues 557 to 582 abolished hr5 binding by IE1 from transfected cell extracts (23) . Our study thus attributes the loss of hr5 binding to defective oligomerization.
By analogy to b-HLH proteins, it was expected that the basic residues preceding the putative HLH motif of IE1 would contribute to IE1 DNA binding but not dimerization. Although substitution R 537 A/R 538 A failed to bind the 28-mer as a homodimer or as a heterodimer with IE1 ⌬9-52 , substitution R 524 A/K 526 A exhibited wild-type DNA binding (Fig. 8) . Thus, the IE1 residues that participate in direct DNA binding may be located elsewhere, possibly within the basic region flanking residue 156. Further studies are required to identify the IE1 residues involved in DNA binding (Fig. 9) and to define the molecular mechanism wherein DNA binding is an obligatory step in IE1-mediated transactivation of the AcMNPV hr enhancers.
